PTSD: Tijaabada Bukaan-jiidka ee ugu Horreysa ee Bukaan-jiifka Hadda oo Hal Mar Daaweyn Maalinle ah

Siideynta Xorta ah ee HAYS 6 | eTurboNews | eTN
Written by Linda Hohnholz

Jazz Pharmaceuticals plc ayaa maanta ku dhawaaqday in bukaankii ugu horreeyay lagu diiwaan geliyay tijaabada bukaan-socodka ee Wajiga 2 ee qiimeynta badbaadada iyo waxtarka JZP150, oo ah baaritaanka fasalka koowaad ee fasalka yar ee daaweynta dadka qaangaarka ah ee qaba xanuunka walaaca ee post-traumatic stress (PTSD). JZP150 waa xakameyn aad u dooratey enzyme fatty acid amide hydrolase (FAAH), oo loogu talagalay in lagu xalliyo sababta asaasiga ah ee PTSD (naafanimada cabsida cabsida iyo xoojinta), iyo sidoo kale calaamadaha la xidhiidha bukaanka (walwal, hurdo la'aan iyo riyooyin).

<

JZP150 waxa la siiyay Magacaabista Fast Track Maamulka Cuntada iyo Dawooyinka ee Maraykanka (FDA) ee PTSD iyadoo lagu salaynayo nooca halista ah ee xanuunka. Sida laga soo xigtay FDA, magacaabistan waxaa loogu talagalay in lagu fududeeyo horumarinta oo la dedejiyo dib u eegista daawooyinka daaweeya xaaladaha halista ah oo awood u leh inay wax ka qabtaan baahiyaha caafimaad ee aan la daboolin.

"Fadiyaha Jidka degdega ah ee FDA ee JZP150 waa aqoonsi caan ah labadaba baahida caafimaad ee halista ah, socota, aan la daboolin ee bukaannada PTSD iyo faa'iidooyinka suurtagalka ah ee habka cusub ee JZP150 ee lagu daweeyo xanuunkan daciifka ah," ayuu yiri Rob Iannone, MD, MSCE, madaxweyne ku xigeenka fulinta. , cilmi-baarista iyo horumarinta iyo madaxa caafimaadka ee Jazz Pharmaceuticals. "Culayska cudurka PTSD wuxuu saameyn xun ku yeelan karaa bukaannada iyo qoysaskooda xaaladdan caadiga ah halkaas oo fiditaanka la filayo inuu kordho. Jazz waxay u heellan tahay horumarinta iyo ka ganacsiga dawooyinka hal-abuurka leh iyo horumarinta horumarka kiliinikada ee JZP150 waa bilawga safar macno leh oo lagu caawinayo dadka qaba PTSD."

PTSD waa xanuunka dhimirka oo saameeya malaayiin dad ah iyo bukaannada ayaa inta badan leh calaamado aan la xakameynin kuwaas oo saameeya awoodda ay u leeyihiin inay qabtaan hawlo nolol maalmeedka iyo u shaqeynta bulsho ahaan. Daawooyinka hadda la ansixiyay waxay leeyihiin waxtarkoodu xaddidan yahay mana jirto daawo loo heli karo xaaladda. Kaliya laba dawo oo niyad-jabka ah ayaa oggolaansho ka helay FDA ee daawaynta calaamadaha PTSD 20kii sano ee la soo dhaafay. Ma jiro daawayn la ansixiyay oo bar-tilmaameedsaday bayoolaji hoose oo u beddela dhacdooyinka naxdinta leh iyo waayo-aragnimada jirrada caafimaadka dhimirka ee daba dheeraatay ee PTSD. 

"PTSD waxay si qoto dheer u saamaysaa nolosha, cilaaqaadka iyo xirfadaha dadka la nool xanuunka. Waxaan u baahanahay daawayn wanaagsan si aan u caawino kuwa dhibaataysan inay dib u soo ceshadaan noloshooda, "ayuu yiri John H. Krystal, MD, Robert L. McNeil Jr., borofisar cilmi-baarista tarjumaadda iyo borofisar ku takhasusay cilmi nafsiga, cilmiga neerfaha, iyo cilmi-nafsiga ee Jaamacadda Yale. "JZP150 waxay beegsataa hab cusub oo maskaxda ah, tijaabadan cusub ee Wajiga 2 ee PTSD waxay naga caawin doontaa inaan wax badan ka ogaano badbaadada molecule iyo waxtarka sida daawaynta suurtagalka ah ee bukaanada ka faa'iideysan doona daaweynta cusub."

Ku saabsan Tijaabada Wajiga 2

Xarunta-badan, laba-indho-la'aanta, tijaabada caafimaad ee la xakameynayo ee placebo ayaa qiimeyn doonta laba qiyaasood oo JZP150 ah, waxaana lagu qabtaa 40 goobood oo daraasado ah oo Maraykan ah. Tijaabadu waxay diwaangelin doontaa 270 qaangaar ah oo ay da'doodu u dhaxayso 18 ilaa 70 laga helay PTSD iyadoo la adeegsanayo shuruudaha Ururka Cilmi-nafsiga ee Maraykanka ee Cilad-sheegida iyo Buuga Tirakoobka Cudurrada Maskaxda, daabacaadda 5-aad (DSM-5).

Meesha ugu dambeysa ee tijaabada waxay cabbirtaa isbeddelada ka qaybgalayaasha laga bilaabo bilawga daraasadda ilaa dhammaadka daawaynta iyadoo la isticmaalayo dhibcaha laga helay Miisaanka PTSD-Kliinikada-Maareeyo (CAPS-5). CAPS-5 waa waraysi caafimaad oo habaysan waxaana loo arkaa heerka dahabka ee ogaanshaha iyo qiimaynta bukaanka qaba PTSD. Waxaa ku jira 30 shay oo ay takhaatiirtu ku samayn karaan baaritaannada PTSD oo ay qiimeeyaan darnaanta calaamadaha iyo sidoo kale saameynta ay ku leeyihiin shaqada bulshada iyo shaqada. Tijaabadu waxay leedahay dhawr dhibcood oo labaad, oo ay ku jiraan isbeddelada buundooyinka ku saabsan Daranaanshaha Aragtida Caalamiga ah ee Clinical iyo Aragtida Caalamiga ah ee Bukaanka ee miisaanka darnaanta laga bilaabo bilawga daraasadda ilaa dhammaadka daaweynta.              

Ku saabsan JZP150

JZP150 waa unug yar oo baaris ah oo loo qaabeeyey si loo xakameeyo enzyme fatty acid amide hydrolase (FAAH) waxayna hadda ku jirtaa horumarinta daaweynta xanuunka murugada ka dib (PTSD) ee dadka waaweyn. PTSD dhexdeeda, cabsida dabar goynta waxay gacan ka geysataa sii jirista xusuusta naxdinta leh. Faragelinta lagu horumarinayo barashada dabar goynta cabsida ayaa ah aasaaska daaweynta PTSD. Daawooyinka dawooyinka ee safka hore ee hadda jira, sida xakamaynta dib u soo celinta serotonin ee la xushay, waxay yareeyaan calaamadaha PTSD qaarkood, laakiin looma qorshayn inay wax ka qabtaan dhibaatada salka u ah (barashada bakhtiinta iyo xoojinta). Xogta laga helay daraasadihii hore ee hore iyo kuwa kiliinikada ee JZP150 waxay bixiyaan caddaynta in joojinta FAAH ay hagaajin karto dib u soo celinta xusuusta bakhtiinta cabsida oo ay hoos u dhigto saameynta anxiogenic ee diiqada.

Jazz waxa uu helay xuquuqaha caalamiga ah ee JZP150, oo hore loo odhan jiray PF-04457845, laga soo qaatay SpringWorks Therapeutics Oktoobar 2020. Pfizer Inc. waxay asal ahaan heshay oo soo saartay molecule oo si gaar ah shati ugu siisay SpringWorks.

Ku Saabsan Xanuunka Cadaadiska Dhaawaca Ka Dambeeyay

Xanuunka walbahaarka ee daba-galka ah (PTSD) waa xaalad maskaxeed oo caadi ah oo ka dhalan karta si toos ah ama si aan toos ahayn u soo-gaadhista dhacdooyinka iyo khibradaha dhaawacyada. Shakhsiyaadka qaba PTSD waxay leeyihiin fikrado iyo dareen murugo leh oo la xidhiidha waayo-aragnimadooda oo sii socota muddo dheer ka dib dhacdada naxdinta leh, waxaana laga yaabaa inay dib u soo nooleeyaan dhacdada iyaga oo soo noqnoqda ama riyooyin waxayna dareemaan murugo, cabsi, xanaaq, iyo ka go'aan dadka kale. Culayska PTSD waa mid aad u weyn iyadoo bukaannada ay la halgamayaan inay xakameeyaan astaamahooda, qabtaan hawlo maalmeed oo ay u shaqeeyaan bulsho ahaan. Waxaa jirta baahi weyn oo aan la daboolin oo loo qabo bukaanada qaba PTSD maadaama aysan jirin daawayn daaweynaysa sababta asaasiga ah ee xanuunka.

MAXAA LAGU QAADAYAA MAQAALKAN:

  • “JZP150 targets a novel mechanism in the brain, and this new Phase 2 trial in PTSD will help us to learn more about the molecule’s safety and effectiveness as a potential treatment for patients who would benefit from a novel therapy.
  • Jazz is dedicated to developing and commercializing innovative medicines and progressing the clinical development of JZP150 is the start to a meaningful journey to help people living with PTSD.
  • “FDA’s Fast Track designation of JZP150 is a notable recognition of both the serious, ongoing, unmet medical needs of PTSD patients and the potential benefits of JZP150’s novel mechanism to treat this debilitating disorder,”.

War ku saabsan qoraaga

Linda Hohnholz

Tafatiraha guud ee eTurboNews ku salaysan eTN HQ.

Rukumo
Ogeysii
martida
0 Comments
Jawaabaha Gudaha ah
Eeg dhammaan faallooyinka
0
Waan jeclaan lahaa fikradahaaga, fadlan faallo ka bixi.x
()
x
La wadaag...